Katie Ellias
InvestorManaging Partner at JDRF T1D Fund · Venture Partner at Zubi Capital
Boston, Massachusetts
Writes $100K – $5M checks · typically $1.5M
Find your path to Katie
808 people in our graph share verified history with Katie — schools, employers, funds. One of them is your warm intro.
René KuijtenunlockedKatie: together at McKinsey & Company (2000–2002)
×4Katie: together at Yale University
×5Katie: together at McKinsey & Company
Katie: together at Partners Healthcare
About
Katie Ellias is a Venture Partner at Zubi Capital with over a decade of venture capital experience in life sciences, including biotech, medical devices, and digital health. She previously served as Managing Director of a single disease impact fund focused on venture philanthropy from 2018 to 2024, and has held board director and observer positions at 12+ early and later-stage companies across the US, Canada, and Europe. Her background includes product launches in interventional cardiology and expertise in cardiac surgery, structural heart, diabetes, and global M&A transactions.
Experience
- Zubi CapitalVenture Partnercurrent2025 — present
- KE Advisory LLCAdvisor/Consultantcurrent2025 — presentCambridge, MA
- SAb BiotherapeuticsBoard Membercurrent2023 — present
- FACCNE ⎮ French-American Chamber of Commerce, New EnglandBoard Membercurrent2025 — presentBoston, Massachusetts, United States
- WHARTON HEALTH CARE MANAGEMENT ALUMNI ASSOCIATIONVice President and Board Membercurrent2021 — presentPhiladelphia, Pennsylvania, United States
- T1D FundManaging Director2018 — 2024Boston, Massachusetts, United States
- SeraxisBoard Observer2021 — 2024Germantown, Maryland, United States
- DiogenXBoard Member2020 — 2024Marseille, Provence-Alpes-Côte d'Azur, France
- i2o TherapeuticsBoard Observer2020 — 2024Cambridge, Massachusetts, United States
- BiolinqBoard Observer2019 — 2024San Diego, California, United States
- VERALOX TherapeuticsBoard Member2019 — 2024Frederick, Maryland, United States
- Enthera PharmaceuticalsBoard Observer2018 — 2024Milan, Lombardy, Italy
- Capillary BiomedicalBoard Member2019 — 2022Irvine, California, United States
- Inversago PharmaBoard Observer2019 — 2021Montreal, Quebec, Canada
- Protomer TechnologiesBoard Observer2020 — 2021Pasadena, California, United States
- Pandion Therapeutics (acquired by Merck)Board Observer2019 — 2020Cambridge, Massachusetts, United States
- Tech HealthIndependent Consultant2017 — 2018Greater Paris Metropolitan Region
- Endeavour VisionSenior Investment Director2016 — 2017Geneva, Paris
- Sofinnova PartnersPrincipal2011 — 2016Greater Paris Metropolitan Region
- MedtronicProgram Director Medtronic EUreka2009 — 2011Lausanne, Vaud, Switzerland
- MedtronicGroup Marketing Manager2009 — 2011Lausanne, Vaud, Switzerland
- MedtronicAd interim Business Director, Coronary Europe2010 — 2011Lausanne, Vaud, Switzerland
- MedtronicProduct Marketing Manager2008 — 2009Lausanne, Vaud, Switzerland
- MedtronicSenior Associate of Business Development2006 — 2008Minneapolis
- Partners HealthcareContracting Senior Associate2002 — 2004Boston
- McKinsey & CompanyBusiness Analyst2000 — 2002Boston
Skills & more
StartupsVenture FinancingExecutive Coaching1Compensation Committee1Cross border1FinanceBoard DevelopmentDue DiligenceInternational Business DevelopmentDeal ExecutionInterpersonal SkillsBoard Level
+12 more
Business DevelopmentProduct LaunchMarketingNegotiationInterventional CardiologyCardiac SurgeryMedical DevicesCommercializationStrategyManagementLeadershipCross-functional Team LeadershipLanguages English · French
From Katie's professional profile.
Colleagues at JDRF T1D Fund
Aaron J. Kowalski
Board of Directors at JDRF T1D Fund
Adam King
Vice President at GroundForce Capital
Brady Bohrmann
Investment Committee at JDRF T1D Fund
Dan McNamara
Head of Strategy & Industry Engagement at JDRF T1D Fund
Daniel Flicker
Senior Associate at JDRF T1D Fund
Elizabeth Mily
CEO at JDRF T1D Fund
Eric Shen
Chief of Staff at JDRF T1D Fund
Ethan Sohn
Principal at Toyota Ventures
Frequently asked questions
- Who is Katie Ellias?
- Katie Ellias is a Venture Partner at Zubi Capital with over a decade of venture capital experience in life sciences, including biotech, medical devices, and digital health. She previously served as Managing Director of a single disease impact fund focused on venture philanthropy from 2018 to 2024, and has held board director and observer positions at 12+ early and later-stage companies across the US, Canada, and Europe. Her background includes product launches in interventional cardiology and expertise in cardiac surgery, structural heart, diabetes, and global M&A transactions.
- Where does Katie Ellias work?
- Katie Ellias is Managing Partner at JDRF T1D Fund.
- What check size does Katie Ellias write?
- Katie Ellias typically writes checks of $100K – $5M.
- Where did Katie Ellias go to school?
- Katie Ellias studied at The Wharton School (MBA, Health Care); Yale University (BA, Political Science); BB&N.
Same school
Also attended The Wharton School2,000
Fred WilsonCo-founder & Partner at Union Square VenturesSarah GuoFounder & General Partner of ConvictionJosh KopelmanFounder and Partner at First Round CapitalAydin SenkutFounder & Managing Partner at FelicisKunal BahlCo-founder of Snapdeal; co-founder of Titan CapitalJack AbrahamFounder, CEO & Managing Partner of Atomic
+ 1,994 more
Shared employers
Also worked at T1D Fund16
Clay RowlandInvestment Associate at Mission BiocapitalSean O'ConnorPrincipal at Longwood FundValerie SuAssociate at JDRF T1D FundDaniel FlickerSenior Associate at JDRF T1D FundSylvia TobéManaging Director at JDRF T1D FundMorgan JanesAssociate at JDRF T1D Fund
+ 10 more
